GlassScriptPhysician profile
Janelle K Artz
NPI 1366741688
$1,192.81
in general payments reported to CMS, 2019-2025
14 companies · $164 in 2025
The $164 reported for 2025 was more than what 77% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $54.64 · 2021: $101 · 2022: $11.89 · 2023: $186 · 2024: $421 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $296.83 | 2019-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $245.19 | 2019-2025 | Xifaxan, Trulance |
| Regeneron Healthcare Solutions, INC. | $180.59 | 2023-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $155.70 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $128.78 | 2024 | Exparel |
| Braintree Laboratories, INC. | $32.35 | 2023-2025 | Sutab, Suflave |
| Ucb, INC. | $30.39 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $23.38 | 2019 | |
| Vyaire Medical, INC. | $21.15 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.03 | 2021 | |
| Ardelyx, INC. | $18.17 | 2024 | Ibsrela |
| Stryker Corporation | $15.34 | 2024 | Scopis Ent |
| Ironwood Pharmaceuticals, INC | $14.02 | 2023 | Linzess |
| Vivus LLC | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janelle Artz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.